Recent advances in "smart" delivery systems for extended drug release in cancer therapy

Recent advances in "smart" delivery systems for extended drug release in cancer therapy

Regina-Veronicka Kalaydina,1,* Komal Bajwa,2,* Bessi Qorri,1,* Alexandria Decarlo,3 Myron R Szewczuk1 1Department of Biomedical and Molecular Sciences, Queen’s University, 2Postgraduate Medical Education, Graduate Diploma and Professional Master in Medical Sciences, School of Medicine, Que...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kalaydina RV, Bajwa K, Qorri B, Decarlo A, Szewczuk MR
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
nanomedicine
“smart” delivery systems
extended-drug release
personalized medicine
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/0dd2289ae4124e4ab39786ecebf6ac0a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0dd2289ae4124e4ab39786ecebf6ac0a
record_format dspace
spelling oai:doaj.org-article:0dd2289ae4124e4ab39786ecebf6ac0a2021-12-02T05:58:10ZRecent advances in "smart" delivery systems for extended drug release in cancer therapy1178-2013https://doaj.org/article/0dd2289ae4124e4ab39786ecebf6ac0a2018-08-01T00:00:00Zhttps://www.dovepress.com/recent-advances-in-smart-delivery-systems-for-extended-drug-release-in-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Regina-Veronicka Kalaydina,1,* Komal Bajwa,2,* Bessi Qorri,1,* Alexandria Decarlo,3 Myron R Szewczuk1 1Department of Biomedical and Molecular Sciences, Queen’s University, 2Postgraduate Medical Education, Graduate Diploma and Professional Master in Medical Sciences, School of Medicine, Queen’s University, 3Department of Biology, Queen’s University, Kingston, ON, Canada *These authors contributed equally to this work Abstract: Advances in nanomedicine have become indispensable for targeted drug delivery, early detection, and increasingly personalized approaches to cancer treatment. Nanoparticle-based drug-delivery systems have overcome some of the limitations associated with traditional cancer-therapy administration, such as reduced drug solubility, chemoresistance, systemic toxicity, narrow therapeutic indices, and poor oral bioavailability. Advances in the field of nanomedicine include “smart” drug delivery, or multiple levels of targeting, and extended-release drug-delivery systems that provide additional methods of overcoming these limitations. More recently, the idea of combining smart drug delivery with extended-release has emerged in hopes of developing highly efficient nanoparticles with improved delivery, bioavailability, and safety profiles. Although functionalized and extended-release drug-delivery systems have been studied extensively, there remain gaps in the literature concerning their application in cancer treatment. We aim to provide an overview of smart and extended-release drug-delivery systems for the delivery of cancer therapies, as well as to introduce innovative advancements in nanoparticle design incorporating these principles. With the growing need for increasingly personalized medicine in cancer treatment, smart extended-release nanoparticles have the potential to enhance chemotherapy delivery, patient adherence, and treatment outcomes in cancer patients. Keywords: nanomedicine, smart delivery systems, extended drug release, personalized medicineKalaydina RVBajwa KQorri BDecarlo ASzewczuk MRDove Medical Pressarticlenanomedicine“smart” delivery systemsextended-drug releasepersonalized medicineMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 13, Pp 4727-4745 (2018)
institution DOAJ
collection DOAJ
language EN
topic nanomedicine
“smart” delivery systems
extended-drug release
personalized medicine
Medicine (General)
R5-920
spellingShingle nanomedicine
“smart” delivery systems
extended-drug release
personalized medicine
Medicine (General)
R5-920
Kalaydina RV
Bajwa K
Qorri B
Decarlo A
Szewczuk MR
Recent advances in "smart" delivery systems for extended drug release in cancer therapy
description Regina-Veronicka Kalaydina,1,* Komal Bajwa,2,* Bessi Qorri,1,* Alexandria Decarlo,3 Myron R Szewczuk1 1Department of Biomedical and Molecular Sciences, Queen’s University, 2Postgraduate Medical Education, Graduate Diploma and Professional Master in Medical Sciences, School of Medicine, Queen’s University, 3Department of Biology, Queen’s University, Kingston, ON, Canada *These authors contributed equally to this work Abstract: Advances in nanomedicine have become indispensable for targeted drug delivery, early detection, and increasingly personalized approaches to cancer treatment. Nanoparticle-based drug-delivery systems have overcome some of the limitations associated with traditional cancer-therapy administration, such as reduced drug solubility, chemoresistance, systemic toxicity, narrow therapeutic indices, and poor oral bioavailability. Advances in the field of nanomedicine include “smart” drug delivery, or multiple levels of targeting, and extended-release drug-delivery systems that provide additional methods of overcoming these limitations. More recently, the idea of combining smart drug delivery with extended-release has emerged in hopes of developing highly efficient nanoparticles with improved delivery, bioavailability, and safety profiles. Although functionalized and extended-release drug-delivery systems have been studied extensively, there remain gaps in the literature concerning their application in cancer treatment. We aim to provide an overview of smart and extended-release drug-delivery systems for the delivery of cancer therapies, as well as to introduce innovative advancements in nanoparticle design incorporating these principles. With the growing need for increasingly personalized medicine in cancer treatment, smart extended-release nanoparticles have the potential to enhance chemotherapy delivery, patient adherence, and treatment outcomes in cancer patients. Keywords: nanomedicine, smart delivery systems, extended drug release, personalized medicine
format article
author Kalaydina RV
Bajwa K
Qorri B
Decarlo A
Szewczuk MR
author_facet Kalaydina RV
Bajwa K
Qorri B
Decarlo A
Szewczuk MR
author_sort Kalaydina RV
title Recent advances in "smart" delivery systems for extended drug release in cancer therapy
title_short Recent advances in "smart" delivery systems for extended drug release in cancer therapy
title_full Recent advances in "smart" delivery systems for extended drug release in cancer therapy
title_fullStr Recent advances in "smart" delivery systems for extended drug release in cancer therapy
title_full_unstemmed Recent advances in "smart" delivery systems for extended drug release in cancer therapy
title_sort recent advances in "smart" delivery systems for extended drug release in cancer therapy
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/0dd2289ae4124e4ab39786ecebf6ac0a
work_keys_str_mv AT kalaydinarv recentadvancesinquotsmartquotdeliverysystemsforextendeddrugreleaseincancertherapy
AT bajwak recentadvancesinquotsmartquotdeliverysystemsforextendeddrugreleaseincancertherapy
AT qorrib recentadvancesinquotsmartquotdeliverysystemsforextendeddrugreleaseincancertherapy
AT decarloa recentadvancesinquotsmartquotdeliverysystemsforextendeddrugreleaseincancertherapy
AT szewczukmr recentadvancesinquotsmartquotdeliverysystemsforextendeddrugreleaseincancertherapy
_version_ 1718400093080518656

Ejemplares similares